Adoption of enteral and parenteral nutritional therapies associated with reduced death rate in neoplastic patients
DOI:
https://doi.org/10.11606/issn.2176-7262.v53i2p115-125Keywords:
Nutrition Therapy, Neoplasms, Malnutrition, Enteral Nutrition, Parenteral NutritionAbstract
Study design: Cross-sectional descriptive study. Objective: This study aimed to analyze the association between the adoption of adult enteral and parenteral nutrition and the average length of hospitalization, the average mortality rate, and the average total cost for admissions of neoplastic patients in hospitals in Rio Grande do Sul. Method: The study analyzes the data available obtained at the SIH/SUS in 2017 for hospitals in Rio Grande do Sul state, for specific hospitalizations registered under the main diagnosis Neoplasms (ICD - Chapter II). Data were analyzed through the average value of the main variables as well as the Kruskal Wallis test. Results: Significantly lower death rate was observed in ICU patients who underwent enteral and/or parenteral dietary therapy than patients who did not receive such supplements in cases of malignant esophageal cancer (C15), in the small intestine (C17), and pancreas (C25). The average length of stay and the average total value of hospitalizations of neoplastic patients tend to be higher in patients receiving enteral and/or parenteral dietary therapies, possibly due to the severity of the clinical condition. Conclusions: The adoption of enteral and parenteral nutrition has significant potential to reduce the mortality rate of cancer patients in the digestive system, especially the most severe cases requiring ICU admission
Downloads
References
Somanchi M, Tao X, Mullin GE. The facilitated early enteral and dietary management effectiveness trial in hospitalized patients with malnutrition. J Parenter Enter Nutr 2011; 35: 209–216.
Waitzberg DL, Caiaffa WT, Correia MIT. Hospital malnutrition: the Brazilian national survey (IBRANUTRI): a study of 4000 patients. Nutrition 2001; 17: 573–580.
Dark DS, Pingleton SK. Nutrition and nutritional support in critically ill patients. J Intensive Care Med 1993; 8: 16–33.
Faisy C, Llerena MC, Savalle M, et al. Early ICU energy deficit is a risk factor for Staphylococcus aureus ventilator-associated pneumonia. Chest 2011; 140: 1254–1260.
DeFrances CJ, Lucas CA, Buie VC, et al. 2006 National hospital discharge survey. Natl Health Stat Rep 2008; 5: 1–20.
Lim SL, Ong KCB, Chan YH, et al. Malnutrition and its impact on cost of hospitalization, length of stay, readmission and 3-year mortality. Clin Nutr 2012; 31: 345–350.
Singer P, Hiesmayr M, Biolo G, et al. Pragmatic approach to nutrition in the ICU: expert opinion regarding which calorie protein target. Clin Nutr 2014; 33: 246–251.
Braunschweig C, Gomez S, Sheean PM. Impact of Declines in Nutritional Status on Outcomes in Adult Patients Hospitalized for More Than 7 days. J Am Diet Assoc 2000; 100: 1316–1322.
Corkins MR, Guenter P, DiMaria-Ghalili RA, et al. Malnutrition diagnoses in hospitalized patients: United States, 2010. J Parenter Enter Nutr 2014; 38: 186–195.
Petros S, Horbach M, Seidel F, et al. Hypocaloric vs normocaloric nutrition in critically ill patients: a prospective randomized pilot trial. J Parenter Enter Nutr 2016; 40: 242–249.
Pichard C, Oshima T, Berger MM. Energy deficit is clinically relevant for critically ill patients: yes. Intensive Care Med 2015; 41: 335–338.
Singer P, Berger MM, Van den Berghe G, et al. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 2009; 28: 387–400.
Genton L, Dupertuis YM, Romand J-A, et al. Higher calorie prescription improves nutrient delivery during the first 5 days of enteral nutrition. Clin Nutr 2004; 23: 307–315.
Heyland DK, Dhaliwal R, Wang M, et al. The prevalence of iatrogenic underfeeding in the nutritionally ‘at-risk’critically ill patient: Results of an international, multicenter, prospective study. Clin Nutr 2015; 34: 659–666.
Oshima T, Deutz NE, Doig G, et al. Protein-energy nutrition in the ICU is the power couple: a hypothesis forming analysis. Clin Nutr 2016; 35: 968–974.
Heidegger CP, Berger MM, Graf S, et al. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial. The Lancet 2013; 381: 385–393.
Oshima T, Heidegger C-P, Pichard C. Supplemental parenteral nutrition is the key to prevent energy deficits in critically ill patients. Nutr Clin Pract 2016; 31: 432–437.
Evans RA, Strauss BJG. Cost and benefit of hospital, hospital-in-the-home and ambulatory care nutrition support services. Asia Pac J Clin Nutr 1998; 7: 241–244.
Gramlich L, Kichian K, Pinilla J, et al. Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature. Nutrition 2004; 20: 843–848.
WHO. Cancer, https://www.who.int/news-room/fact-sheets/detail/cancer (2019, accessed 28 May 2019).
INCA. INCA - Instituto Nacional de Câncer. INCA - Instituto Nacional de Câncer, https://www.inca.gov.br/ (2019, accessed 28 May 2019).
Philipson TJ, Snider JT, Lakdawalla DN, et al. Impact of oral nutritional supplementation on hospital outcomes. Am J Manag Care 2013; 19: 121–128.
Elia M, Normand C, Laviano A, et al. A systematic review of the cost and cost effectiveness of using standard oral nutritional supplements in community and care home settings. Clin Nutr 2016; 35: 125–137.
Stratton RJ, Hebuterne X, Elia M. A systematic review and meta-analysis of the impact of oral nutritional supplements on hospital readmissions. Ageing Res Rev 2013; 12: 884–897.
Bozzetti F, Braga M, Gianotti L, et al. Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial. The Lancet 2001; 358: 1487–1492.
Reignier J, Boisramé-Helms J, Brisard L, et al. Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2). The Lancet 2018; 391: 133–143.
Chow R, Bruera E, Chiu L, et al. Enteral and parenteral nutrition in cancer patients: a systematic review and meta-analysis. Ann Palliat Med 2016; 5: 30-41–41.
Seres DS, Valcarcel M, Guillaume A. Advantages of enteral nutrition over parenteral nutrition. Ther Adv Gastroenterol 2013; 6: 157–167.
Zhao X-F, Wu N, Zhao G-Q, et al. Enteral nutrition versus parenteral nutrition after major abdominal surgery in patients with gastrointestinal cancer: a systematic review and meta-analysis. J Investig Med 2016; 64: 1061–1074.
Kreymann KG, Berger MM, Deutz NEP, et al. ESPEN Guidelines on Enteral Nutrition: Intensive care. Clin Nutr 2006; 25: 210–223.
Oliveira E de V. Dieta em UTI, seu reflexo no tratamento, recuperaçäo e custo/dia do paciente internado. Aliment Nutr 1985; 6: 38–40.
Castrao DLL e, Freitas MM de, Zaban ALRS. Terapia nutricional enteral e parenteral: complicações em pacientes críticos - uma revisão de literatura. Comun Ciênc Saúde 2009; 20: 65–74.
Tamiya H, Yasunaga H, Matusi H, et al. Comparison of short-term mortality and morbidity between parenteral and enteral nutrition for adults without cancer: a propensity-matched analysis using a national inpatient database. Am J Clin Nutr 2015; 102: 1222–1228.
Downloads
Published
Issue
Section
License
